Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Aaron Lehman currently holds 252,992 shares of Intersect ENT, Inc. (XENT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Aaron Lehman has been a net seller of XENT stock. They have purchased $0 and sold $7.7M worth of shares.
David Aaron Lehman's most recent insider trade was on Dec 1, 2025, when they sold 3,401 shares at $1.57 per share.
David Aaron Lehman serves as Executive at Intersect ENT, Inc. (XENT). They have executed 133 insider transactions totaling $7.7M over their tenure at the company.
David Aaron Lehman holds the position of Executive at Intersect ENT, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David Aaron Lehman has shown a selling trading pattern, with $0 in total purchases and $7.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Aaron Lehman was on Jan 2, 2020, when they sold $105.6K worth of XENT shares. This transaction involved 4,357 shares at $24.23 per share.
David Aaron Lehman currently owns 252,992 shares of Intersect ENT, Inc. (XENT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Aaron Lehman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Aaron Lehman has 133 Form 4 filings on record as an insider at Intersect ENT, Inc..
Set alerts for David Aaron Lehman and 40,000+ other insiders.